Related by context. All words. (Click for frequent words.) 72 grade glioma 72 grade cervical intraepithelial 70 grade gliomas 67 advanced adenomas 66 grade cervical dysplasia 65 CIN3 65 malignant polyps 65 precursor lesions 64 neoplasia 64 GISTs 64 adenoma 64 intestinal metaplasia 63 dysplasia 63 resectable 63 precancerous spots 63 pre cancerous growths 63 dysplastic lesions 63 CIN2 + 63 pre cancerous polyps 63 varices 63 neoplasia PIN 63 biochemical recurrence 63 malignant lesions 63 advanced adenoma 63 endometrial carcinoma 63 colorectal liver metastases 62 histologically confirmed 62 locoregional recurrence 62 grade prostatic intraepithelial 62 Adenomas 62 epithelial tumors 62 Barrett esophagus 62 adenomatous polyps 62 cervical intraepithelial neoplasia 62 PSADT 62 sentinel nodes 62 myelodysplastic syndrome MDS 62 cytoreductive surgery 62 curative resection 62 precancerous cervical 62 benign polyps 61 adrenalectomy 61 endoscopic resection 61 colorectal neoplasms 61 contralateral breast 61 neoplasm 61 Hurthle cell 61 HGPIN 61 precancers 61 distant metastases 61 hepatic metastases 61 cervical carcinoma 61 cervical lesions 61 asymptomatic carotid stenosis 61 invasive ductal 61 dose cyclophosphamide 61 neoplasias 61 EBRT 61 carotid stenosis 61 atypical ductal hyperplasia 61 PSA nadir 60 pulmonary metastases 60 osteosarcomas 60 esophagitis 60 premalignant lesions 60 node metastases 60 CMV infection 60 underwent resection 60 papillary 60 chronic GVHD 60 cytoreduction 60 ductal breast cancer 60 androgen deprivation 60 grade squamous intraepithelial 60 endometrial hyperplasia 60 histologic subtype 60 gastrointestinal stromal tumor 60 metastatic lesions 60 ovarian tumors 60 CIN2 60 precancerous condition 60 serum phosphate 60 MALT lymphoma 60 pericardial effusion 60 CMV disease 60 precancerous lesions 60 invasive candidiasis 60 intravesical therapy 60 recurrent VTE 60 thromboembolic events 60 chemoradiotherapy 60 differentiated thyroid 60 precancerous cervical lesions 60 serum PSA 60 #.#ng/ml 60 liver resection 60 recurrent glioblastoma multiforme 59 macroalbuminuria 59 hepatocellular carcinomas 59 serum calcium levels 59 smoldering multiple myeloma 59 CIN3 + 59 malignant growths 59 acute aortic dissection 59 benign breast 59 dose cytarabine 59 mucinous 59 B7 H3 59 carcinoids 59 metastatic disease 59 alanine aminotransferase ALT 59 ALND 59 pretest probability 59 dose melphalan 59 metastatic malignant melanoma 59 pCR 59 radioiodine therapy 59 hypercalcemia 59 atypical hyperplasia 59 axillary lymph nodes 59 ductal cancer 59 lymph node metastases 59 mitomycin C 59 renal cell carcinomas 59 urothelial carcinoma 59 resected 59 hyperoxaluria 59 acute GvHD 59 postoperative infections 59 tumor shrinkage 59 proliferative diabetic retinopathy 59 benign nodules 59 colorectal adenoma 59 gastric adenocarcinoma 59 adenomas 59 postoperative chemotherapy 59 liver metastasis 59 tumor recurrence 59 lymph node dissection 59 nonmelanoma skin cancers 59 epithelial ovarian cancer 59 T1a 59 cystectomy 59 indolent NHL 59 axillary lymph node dissection 59 hematologic toxicity 59 paroxysmal AF 59 febrile neutropenia 59 Glioblastoma Multiforme 59 renal tumors 59 symptomatic VTE 59 basal cell nevus syndrome 59 papillary thyroid carcinoma 59 thyroglobulin 59 bone metastasis 59 adenomatous 59 medullary thyroid cancer 59 dysplastic 59 esophageal adenocarcinoma 59 seminoma 59 superficial bladder cancer 59 peritoneal cancer 58 transurethral resection 58 lung nodules 58 mycophenolate mofetil 58 leukemia AML 58 dose dexamethasone 58 radical nephrectomy 58 leiomyomas 58 distant metastasis 58 malignancy 58 surgical excision 58 candidemia 58 liver metastases 58 precancer 58 catheter angiography 58 pneumonectomy 58 lobular carcinoma 58 coronary stenosis 58 anaplastic 58 glycated hemoglobin levels 58 thymoma 58 polyp recurrence 58 proliferative retinopathy 58 ADPKD 58 premalignant 58 endophthalmitis 58 response pCR 58 colorectal polyps 58 HER2 overexpression 58 Squamous 58 epithelial ovarian 58 adjuvant radiotherapy 58 ovarian carcinoma 58 orchiectomy 58 fallopian tube carcinoma 58 underwent surgical resection 58 situ CIS 58 RAS mutations 58 renal scarring 58 IV NSCLC 58 recurrent NSCLC 58 basal cell carcinomas 58 intestinal polyps 58 esophagogastric 58 thromboembolism 58 gout flares 58 intraepithelial neoplasia 58 completely resected 58 peritoneal carcinomatosis 58 HBeAg negative 58 proctitis 58 mg/m2 dose 58 pT3 58 operable breast cancer 58 posterior uveitis 58 relapsed MM 58 Adjuvant chemotherapy 58 thyroid nodules 58 unresectable tumors 58 mRCC 58 pre cancerous lesions 58 thrombotic complications 58 pleural mesothelioma 58 preoperative chemotherapy 58 pre cancerous 58 subclinical hyperthyroidism 58 armpit lymph nodes 58 clinically localized prostate 58 benign proliferative breast 58 stage IIIB 58 ovarian malignancy 58 Tindamax R 58 Radical prostatectomy 58 axillary dissection 58 grade astrocytomas 57 papillomas 57 total thyroidectomy 57 GnRH agonists 57 complete remissions 57 chlamydial infection 57 adjuvant radiation 57 situ DCIS 57 EpCAM expression 57 cancerous lesions 57 NMIBC 57 Basal cell 57 radiotherapy RT 57 colorectal carcinoma 57 platelet reactivity 57 Barrett Esophagus 57 recurrent DVT 57 Chronic Myelogenous Leukemia CML 57 rebleeding 57 invasive aspergillosis 57 contrast induced nephropathy 57 malignant lymphoma 57 mycosis fungoides 57 parathyroid carcinoma 57 PCa 57 pT2 57 colorectal cancer liver metastases 57 relapsing remitting 57 dose corticosteroids 57 lymph node involvement 57 neuroblastoma tumors 57 cisplatin chemotherapy 57 fructose diet 57 BRAF mutations 57 lymphadenectomy 57 elevated IOP 57 prostate cancer CaP 57 myeloproliferative disorders 57 VUR 57 polyps 57 ischemic lesions 57 corticosteroid therapy 57 thromboembolic complications 57 premalignant lesion 57 cytogenetic responses 57 metastatic GIST 57 metastatic malignant 57 vesicoureteral reflux 57 histologically proven 57 pheochromocytoma 57 oophorectomy 57 alemtuzumab treated 57 colectomy 57 IV bisphosphonates 57 precancerous tumors 57 basal cell cancers 57 oesophagitis 57 severe exacerbations 57 biochemical relapse 57 axillary lymph node 57 dose atorvastatin 57 recurrent venous thromboembolism 57 breast lesions 57 dose methotrexate 57 gastric carcinoma 57 FDG uptake 57 PASI scores 57 HNSCC 57 dose colchicine 57 mesotheliomas 57 adjuvant therapy 57 pituitary adenomas 57 chronic periodontitis 57 pancreatic NET 57 radical prostatectomy RP 57 lumbar disk herniation 57 choroidal neovascularization CNV 57 occlusive disease 57 unresectable 57 elevated intraocular pressure 57 bowel polyps 57 sulfasalazine 57 heterotopic ossification 57 nephrotoxicity 57 PAOD 57 hypophosphatemia 57 CLL SLL 57 bullous 57 multimodality therapy 57 virological failure 57 gastrointestinal toxicity 57 carcinoma 57 adenoma recurrence 57 metastatic lung cancer 57 axillary node dissection 57 moderate renal impairment 57 IV melanoma 57 T1c 57 IOP lowering 57 haematologic 57 locoregional 57 prostate cancer CRPC 57 neoadjuvant chemotherapy 57 malignant pleural mesothelioma 57 basal cell carcinoma BCC 57 perioperative mortality 57 Postoperative complications 57 medically inoperable 57 intravenous bisphosphonates 57 malignant neoplasm 57 sustained virologic response 57 antimicrobial prophylaxis 57 H. pylori eradication 57 inflammatory acne 57 pseudoaneurysm 57 elevated CRP 57 gastroduodenal 57 dose cohort 57 surgical debulking 57 varicoceles 57 transitional cell carcinoma 57 TNF antagonist 57 tumor resection 57 hematopoietic cancers 56 external genital lesions 56 AGHD 56 SUVmax 56 histologic diagnosis 56 BRAF mutation 56 CTEPH 56 ductal carcinomas 56 serum creatinine levels 56 cervical dysplasia 56 pediatric malignancies 56 hepatorenal syndrome 56 proteinuria 56 Candida infection 56 overt nephropathy 56 neoadjuvant therapy 56 curable cancers 56 post thrombotic syndrome 56 hamartomas 56 metachronous 56 abnormal Pap smears 56 spiral computed tomography 56 standard chemotherapy regimen 56 bone scintigraphy 56 MCyR 56 neoplastic lesions 56 breast carcinomas 56 rapid virologic response 56 histopathologic examination 56 cancerous polyps 56 CYT# potent vascular disrupting 56 pre cancerous lesion 56 transaminase levels 56 DFMO 56 density lipoprotein HDL cholesterol 56 EUS FNA 56 invasive coronary angiography 56 cutaneous melanoma 56 LTBI 56 squamous cell carcinomas 56 pancreatic adenocarcinoma 56 pelvic lymphadenectomy 56 hyperkalemia 56 SLNB 56 B Cell Lymphoma 56 5-FU/LV 56 ALA PDT 56 antithrombotic therapy 56 ventricular tachyarrhythmia 56 EXJADE 56 choroidal neovascularization 56 hsCRP levels 56 prostate carcinoma 56 thoracoscopic lobectomy 56 esophagectomy 56 urolithiasis 56 bowel resection 56 nanomolar 56 asymptomatic 56 pentoxifylline 56 bladder tumors 56 postoperative mortality 56 neovascular 56 nonvertebral fractures 56 plasma uric acid 56 TURP 56 dose Iluvien 56 latent tuberculosis infection 56 external beam radiotherapy 56 abnormal pap smears 56 lymphocytosis 56 excisional biopsy 56 BRCA mutation carriers 56 anterior uveitis 56 nonalcoholic steatohepatitis 56 nonalcoholic steatohepatitis NASH 56 microscopic hematuria 56 Barrett esophagus BE 56 complete cytogenetic response 56 benign lesions 56 parathyroid 56 sentinel lymph nodes 56 mucosal healing 56 TTF Therapy 56 severe renal impairment 56 DCIS lesions 56 undetectable HBV DNA 56 invasive carcinoma 56 steatohepatitis 56 cytogenetic response 56 gastrointestinal stromal tumor GIST 56 advanced neoplasia 56 idiopathic PAH 56 troponin T 56 leiomyosarcoma 56 serum calcium 56 prostate TURP 56 Candida infections 56 serous ovarian cancer 56 gastroesophageal junction 56 bladder cancers 56 esophageal candidiasis 56 smoldering myeloma 56 TMP SMX 56 axillary nodes 56 precancerous polyp 56 follicular lymphoma FL 56 soft tissue sarcomas 56 Toxicities 56 prostate cancer metastases 56 hemorrhagic complications 56 idarubicin 56 atypia 56 bronchogenic carcinoma 56 vertebral fracture 56 antihypertensive therapy 56 lichen planus 56 postoperative pulmonary 56 chemoradiation therapy 56 sleeve lobectomy 56 metastatic bladder 56 nonproliferative 56 invasive fungal infections 56 docetaxel Taxotere ® 56 prostate adenocarcinoma 56 adenocarcinomas 56 bone erosions 56 myelofibrosis polycythemia vera 56 herpetic 56 detrusor overactivity 56 invasive lobular 56 prostate cancer PCa 56 cranial radiation 56 glioblastomas 56 N. gonorrhoeae 56 serum testosterone 56 hyperphenylalaninemia HPA due 56 evaluable subjects 56 fasting triglyceride levels 56 D dimer 56 lymphadenopathy 56 thyroidectomy 56 upper gastrointestinal bleeding 56 malignant neoplasms 56 gastric cancers 56 aminotransferase levels 56 neoplasms 56 Wegener granulomatosis 56 micrometastases 56 pulmonary infiltrates 56 endometrial cancers 56 undergone radical prostatectomy 56 skeletal metastases 56 Radiofrequency ablation 56 graft dysfunction 56 astrocytoma 56 HER2 negative 56 myocardial ischemia 56 breast carcinoma 56 gastrointestinal stromal tumors 56 Acute Myeloid Leukaemia AML 56 neutrophil counts 55 antigen PSA levels 55 neoplastic 55 pulmonary hypertension PH 55 situ LCIS 55 histologically 55 postoperative complication 55 follicular thyroid cancer 55 cranial irradiation 55 hyperplastic 55 imatinib therapy 55 dose cohorts 55 resected pancreatic cancer 55 Pseudomonas aeruginosa infections 55 postoperative atrial fibrillation 55 esophageal cancers 55 prednisone prednisolone 55 biopsies 55 nephrectomy 55 carcinoid tumors 55 squamous 55 elevated ALT 55 vulvar intraepithelial neoplasia 55 osteoid osteoma 55 cytopenias 55 nodal metastases 55 lymph node metastasis 55 postoperative infection 55 tumor necrosis 55 precancerous 55 anogenital warts 55 KRAS mutations occur 55 node dissection 55 amenorrhoea 55 chemotherapeutic regimens 55 cTnT 55 mitral regurgitation 55 HBeAg seroconversion 55 hepatocellular 55 cell carcinomas 55 cell carcinoma 55 allogeneic stem cell 55 duplex ultrasonography 55 astrocytomas 55 vaginal lesions 55 unruptured aneurysms 55 carcinoid tumor 55 antibody titer 55 mildly symptomatic 55 penetrance 55 Follicular Lymphoma 55 gemcitabine carboplatin 55 malignant nodules 55 proximal colon 55 macrolide antibiotic 55 sCJD 55 dose ionizing radiation 55 cholangiocarcinoma 55 Duodenal 55 transferrin saturation 55 allograft rejection 55 systemic corticosteroids 55 carcinoid 55 QTc prolongation 55 seminomas 55 Polyps 55 gastrointestinal stromal tumors GIST 55 remission CR 55 sonographic findings 55 blood phenylalanine Phe 55 R0 resection 55 hypercalciuria 55 octreotide 55 extracranial 55 venous blood clots 55 radiographic progression 55 idraparinux 55 CrCl 55 standard chemotherapy regimens 55 invasive fungal infection 55 MS relapses 55 serum urate levels 55 sarcomatoid 55 cervical lymph nodes 55 pleural effusions 55 colon polyps 55 thyrotoxicosis 55 fibroadenomas 55 polyposis 55 postoperative pathology 55 receiving VICTRELIS 55 diabetes mellitus DM 55 ASCUS 55 histological subtype 55 liver scarring 55 hypervascular tumors 55 pyelonephritis 55 orchitis 55 indolent lymphomas 55 urate levels 55 prophylactic cranial irradiation 55 Hepatocellular Carcinoma HCC 55 renal dysfunction 55 carotid endarterectomy CEA 55 metastatic CRC 55 cutaneous squamous cell carcinoma 55 colorectal adenomas 55 aminotransferases 55 polypoid 55 BENICAR HCT 55 serum clusterin levels 55 lesions 55 postoperative complications 55 neoadjuvant radiation 55 trans retinoic acid 55 amyloid deposition 55 follicular lymphoma 55 stenoses 55 neuroendocrine cancers 55 paragangliomas 55 Surgical resection 55 non metastatic osteosarcoma 55 chronic HCV infection 55 PUVA 55 thrombi 55 dysplasias 55 specific antigen PSA 55 systemic corticosteroid 55 Aspergillus infections 55 genital herpes infections 55 microvascular disease 55 BEACOPP 55 pulmonary emboli 55 para aortic 55 Circulating tumor cells 55 idiopathic scoliosis 55 FOLFOX6 55 chemoembolization 55 severe oral mucositis 55 PCA3 scores 55 gastrointestinal cancers 55 beta blocker therapy 55 neutrophil count 55 neurological manifestations 55 relapsed Acute Myeloid 55 recurrent genital herpes 55 five MDS subtypes 55 neurologic deficits 55 invasive ductal breast cancer 55 MULTAQ 55 graft occlusion 55 dexamethasone Decadron 55 intraperitoneal chemotherapy 55 HER2 positive cancers 55 FDG-PET/CT 55 squamous cell 55 myeloproliferative diseases 55 onset diabetes mellitus 55 GI bleeding 55 metastatic RCC 55 nodular 55 octreotide LAR 55 parasitaemia 55 nonmelanoma skin cancer 55 metastatic gastric 55 bacterial prostatitis 55 wound dehiscence 55 adenocarcinoma 55 diskectomy 55 wedge resection 55 untreated celiac disease 55 ertapenem 55 uveal melanoma 55 metastatic renal cell carcinoma 55 invasive carcinomas 55 saphenous vein grafts 55 Papillary 55 severe neutropenia 55 STRIDE PD 55 riociguat 55 HPV# 55 colorectal tumors 55 MACCE 55 pyrazinamide 55 Carcinoma 55 leukemia ALL 55 lipid abnormalities 55 FOLFOX4 55 torsade de pointes 55 hypersensitivity reaction 55 perioperative morbidity 55 gadolinium enhanced 55 follicular NHL 55 pelvic lymph nodes 55 lymphatic tissue 55 variceal hemorrhage 55 serum ALT 55 sentinel lymph node biopsy 55 Sentinel node biopsy 55 microvascular complications 55 abnormal cytology 54 cystoscopic 54 HSCT 54 taxane chemotherapy 54 rosuvastatin #mg 54 virologic failure 54 transplantation HCT 54 antibiotic prophylaxis 54 rheumatoid factor 54 tyrosine kinase inhibitors TKIs 54 hypereosinophilic syndrome 54 SHBG levels 54 malignant fibrous histiocytoma 54 erlotinib Tarceva ® 54 glomerular filtration 54 TACE 54 A1c levels 54 ara C 54 atrioventricular block 54 extracolonic findings 54 subtrochanteric 54 lung metastasis 54 anthracycline containing 54 VFEND 54 ependymoma 54 cerebral angiography 54 colorectal adenocarcinoma 54 thalidomide Thalomid 54 squamous intraepithelial lesions 54 exemestane Aromasin 54 primary hyperparathyroidism 54 acetabular dysplasia 54 cirrhotic patients 54 prostate biopsy 54 coronary artery stenosis 54 dysplastic nevi 54 FluCAM arm 54 NAbs 54 non squamous NSCLC 54 virologic response 54 pathologic diagnosis 54 transfusion syndrome 54 infective endocarditis 54 bladder carcinoma 54 hypertrophic scars 54 serum aminotransferase levels 54 gastric atrophy 54 alanine aminotransferase 54 RF ablation 54 CCyR 54 mammographic density 54 postoperative morbidity 54 transaminases 54 T2DM 54 colorectal polyp 54 HER2 expression 54 morphometric vertebral fractures 54 stent implantation 54 radiofrequency ablation RFA 54 hamartoma 54 pleural fluid 54 dose clopidogrel 54 SGPT 54 cirrhosis liver failure 54 artery stenosis 54 placenta accreta 54 immunosuppressive regimen 54 spinal metastases 54 corticosteroid dexamethasone 54 adenomyosis 54 urethral stricture 54 sentinel node 54 venous thromboembolism 54 severe rotavirus gastroenteritis 54 myeloid leukemia 54 Trastuzumab 54 ocular toxicity 54 malignancies 54 recurrent glioblastoma 54 OAB symptoms 54 Natalizumab 54 Colon polyps 54 small lymphocytic lymphoma 54 hematuria 54 superficial basal cell carcinoma 54 geographic atrophy 54 colonic polyps 54 myelodysplastic myeloproliferative diseases 54 reinfarction 54 vWD 54 mucosal lesions 54 mL/min/#.# m 2 54 lymphovascular invasion 54 meningiomas 54 cholelithiasis 54 HIV HCV coinfected 54 serum potassium levels 54 GvHD 54 dasatinib 54 hypercholesterolaemia 54 GnRH agonist 54 hepatocellular cancer 54 choriocarcinoma 54 clodronate 54 definite stent thrombosis 54 epirubicin 54 ulcerative 54 papillary carcinoma 54 plain radiographs 54 liver biopsy 54 eosinophilic asthma 54 malignant lesion 54 ULORIC 54 squamous cell carcinoma SCC 54 acute STEMI 54 erythrocyte sedimentation rate 54 lactate dehydrogenase LDH 54 vaginal hysterectomy 54 palliation 54 microalbuminuria 54 myelodysplasia 54 paraganglioma 54 aspartate aminotransferase AST 54 lung tumors 54 MGUS 54 intra arterial chemotherapy 54 FASLODEX 54 hiatal hernias 54 antigen PSA 54 immunosuppression 54 nodal metastasis 54 neovascular AMD 54 thromboembolic disease 54 hyperplastic polyps 54 serum phosphorous 54 fibroadenoma 54 teriflunomide 54 adjuvant chemotherapy 54 arthrodesis 54 invasive breast cancer 54 needle aspiration 54 ALT flares 54 hypertensives 54 recurrent bladder 54 hyperintense lesions 54 hormone receptor negative 54 Mitomycin C 54 calcified plaques 54 sustained ventricular tachycardia 54 aneurysm rupture 54 undetectable PSA 54 stratifying patients 54 histologic 54 debilitating complication 54 sentinel node biopsy 54 leiomyoma 54 imiquimod 54 angiosarcoma 54 transesophageal echocardiography 54 detectable HCV RNA 54 Myelofibrosis 54 nodular melanoma 54 Thrombocytopenia 54 basal cell skin 54 necrotizing 54 radiochemotherapy 54 serum LDL cholesterol 54 revascularization procedures 54 squamous cell cancers 54 surgical biopsies 54 HER2 positive 54 intraoperative complications 54 HER2 positive metastatic breast 54 bowel cancers 54 AST ALT 54 chronic hepatitis cirrhosis 54 acute gout flares 54 dose Ara 54 renal biopsy 54 bisphosphonate therapy 54 squamous carcinoma 54 herpes zoster shingles 54 lymph node removal 54 elevated serum creatinine 54 KRAS wild 54 baseline LDH 54 concomitant medications 54 anti androgen 54 lung carcinomas 54 angiographic restenosis 54 bacteraemia 54 prior chemotherapy regimens 54 atherosclerotic disease 54 progesterone receptor negative 54 indolent lymphoma 54 interferon ribavirin 54 obstructive CAD 54 ritonavir boosted 54 Mitoxantrone 54 EGFR mutation 54 tamoxifen therapy 54 androgen suppression therapy 54 sustained virological response 54 sonographically 54 PEGINTRON TM 54 ximelagatran 54 atherothrombotic events 54 Kit CD# positive 54 ventricular dysfunction 54 deep venous thromboses 54 latent celiac disease 54 KRAS mutation 54 liver histology 54 venous reflux 54 cTnT levels 54 elevated LDH 54 chronic HCV 54 DCIS 54 mammographically 54 mediastinal 54 complete cytogenetic 54 IFN beta 54 thromboses 54 Malignant Melanoma 54 generalized seizures 54 NAFLD 54 superficial basal cell carcinomas 54 vasospasm 54 B CLL 54 abnormal lipid 54 prolonged QT interval 54 dopaminergic therapy 54 SHPT 54 Helicobacter pylori eradication 54 neutropaenia 54 systolic hypertension 54 prostate cancers 54 pre malignant lesions 54 breast abscesses 54 arthrography 54 delayed CINV 54 dysmenorrhoea 54 anal canal 54 cell lymphoma ALCL 54 reflux disease 54 malignant transformation 54 GIST tumors 54 endobronchial 54 phase IIb study 54 cardiac dysfunction 54 homozygous familial hypercholesterolemia 54 recanalization 54 hyperplasia BPH 54 abdominal computed tomography 54 ocular disorders 54 prostate carcinomas 54 solar keratoses 54 variceal bleeding 54 thymic carcinoma 54 glycosylated hemoglobin HbA1c 54 antireflux surgery 54 metastatic prostate cancer 54 occult metastases 54 cystic lesions 54 transaminase elevations 54 salpingo oophorectomy 54 BRCA1 mutation carriers 54 HER2 amplification 54 density lipoprotein cholesterol HDL 54 tumor lysis syndrome 54 upper endoscopy 54 autoantibody levels 54 carotid artery stenting 54 POAG 54 Gorlin syndrome 54 arteriography 54 thyroxine 54 essential thrombocythemia 54 Adenocarcinoma 54 gastro esophageal reflux